Hypermarcas (OTCMKTS:HYPMY – Get Free Report) gapped up before the market opened on Monday. The stock had previously closed at $3.94, but opened at $4.0990. Hypermarcas shares last traded at $3.91, with a volume of 3,190 shares traded.
Hypermarcas Price Performance
The business’s fifty day moving average price is $4.58 and its 200-day moving average price is $4.38. The company has a market capitalization of $2.75 billion, a P/E ratio of 7.42 and a beta of 0.78. The company has a current ratio of 1.86, a quick ratio of 1.26 and a debt-to-equity ratio of 0.50.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its quarterly earnings results on Wednesday, November 11th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.01. The business had revenue of $473.13 million during the quarter, compared to the consensus estimate of $450.75 million. Hypermarcas had a net margin of 20.07% and a return on equity of 12.58%. As a group, sell-side analysts predict that Hypermarcas will post 0.50 earnings per share for the current fiscal year.
About Hypermarcas
Hypermarcas was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories. Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo QuĂmica and Mantecorp.
Featured Articles
- Five stocks we like better than Hypermarcas
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
